Detecting sarcopenia in obesity: emerging new approaches

Area of Science:

• Clinical Nutrition
• Obesity Medicine
• Gerontology

Background:

• Sarcopenic obesity, a phenotype combining obesity with muscle loss, presents significant clinical challenges.
• Accurate definition and diagnosis of sarcopenic obesity have historically been difficult.
• This condition is likely underdiagnosed and underestimated in its prevalence and impact.

Purpose of the Study:

• To review recent advancements in the definition and diagnosis of sarcopenic obesity.
• To highlight new international consensus guidelines and their implications.
• To discuss the potential impact of improved diagnostic tools on clinical practice and patient outcomes.

Main Methods:

• Review of recent international consensus reports, including ESPEN-EASO and GLIS initiatives.
• Analysis of proposed diagnostic algorithms and definitions for sarcopenia and sarcopenic obesity.
• Consideration of emerging research on the effects of obesity treatment on muscle function.

Main Results:

• The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) have proposed the first international consensus on sarcopenic obesity diagnosis.
• Initial implementation of the ESPEN-EASO algorithm shows promising results for identifying sarcopenic obesity.
• The Global Leadership Initiative on Sarcopenia (GLIS) has updated the conceptual definition of sarcopenia, including muscle-specific strength, aiding consistent identification.

Conclusions:

• New consensus-based diagnostic tools are expected to increase awareness and understanding of sarcopenic obesity.
• These tools will facilitate better identification and management of this under-recognized obesity phenotype.
• Improved diagnostic accuracy holds the potential to enhance treatment strategies for sarcopenic obesity.